Skip to content

Novo Nordisk Foundation

CHALLENGE PROGRAMME 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections

DKK 30–75 million per grant6 years

Stage 1 (expression of interest) deadline: December 2026; Stage 2: June 2027 — confirm exact dates on the funder page

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →
This is the current call of the Novo Nordisk Foundation Challenge Programme programme. The programme guide covers eligibility, budget, success rate and FAQ across every round.

Details

Funder Novo Nordisk Foundation
Budget DKK 30–75 million per grant
Duration 6 years
Consortium Required — consortium of research partners with a clear vision and mission
Application 2-stage: Stage 1 results December 2026, Stage 2 results June 2027
Frequency One-off
Eligible countries EUCHNOISGB

Recently updated

catalog cleanup 2026-07-04: Oct date was not the published Stage-1 deadline per NNF

Eligibility & scope

Funds leading researchers forming a consortium to develop innovative solutions in AMR diagnostics for lower respiratory tract infections. Open to international applicants (Research Leaders / Established Professors). Supports Danish and European research ecosystems as a strategic priority of the Novo Nordisk Foundation.

Related on Grantsby

More from Novo Nordisk Foundation

Browse all open grants →

Browse Related

Could CHALLENGE PROGRAMME 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →